Risk factors for hypersensitivity reactions to tocilizumab introduction in systemic juvenile idiopathic arthritis
Author:
Affiliation:
1. Department of Infection and Immunology, Aichi Children’s Health and Medical Center, Aichi, Japan;
2. Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan
Publisher
Oxford University Press (OUP)
Subject
Rheumatology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14397595.2018.1457490
Reference16 articles.
1. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions
2. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
3. Clinical features and severity grading of anaphylaxis
4. The Incidence and Management of Infusion Reactions To Infliximab: A Large Center Experience
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immune-related adverse events of biological immunotherapies used in COVID-19;Frontiers in Pharmacology;2022-08-25
2. Severe Immediate and Delayed Hypersensitivity Reactions to Biologics in a Toddler With Systemic Juvenile Idiopathic Arthritis;Journal of Investigative Medicine High Impact Case Reports;2022-01
3. Anaphylaxis to tocilizumab in patients with rheumatic disease;Immunotherapy;2021-12
4. Interstitial lung disease occurring shortly after tocilizumab infusion in a patient with polyarticular juvenile idiopathic arthritis: a case report;Allergy, Asthma & Clinical Immunology;2021-09-08
5. Tocilizumab in management of refractory juvenile idiopathic arthritis, 10 years of experience at tertiary university hospital;Egyptian Rheumatology and Rehabilitation;2021-07-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3